İlaç üretiminde, equipment does not need to be “clean” in an abstract sense—it needs to be clean enough for its intended next use. Pharmaceutical cleaning validation provides documented evidence that an established cleaning procedure can consistently control product residues, cleaning-agent residues, and other relevant contamination risks within defined acceptance criteria.
This matters most when product-contact equipment is reused between batches or different products. A surface that looks clean can still contain residues that are not visible, while detecting a trace residue does not automatically mean the cleaning process has failed. The real question is whether the remaining residue is below a scientifically justified limit and whether the cleaning process can achieve that result consistently.
A sound cleaning validation in the pharmaceutical industry therefore connects four elements: appropriate acceptance criteria, a defined cleaning procedure, representative sampling, and analytical results that can reliably show whether those criteria have been met.
What Is Pharmaceutical Cleaning Validation—and How Clean Is Clean Enough?
Pharmaceutical cleaning validation is the documented process used to demonstrate that an approved cleaning procedure consistently leaves equipment suitable for its intended use. WHO guidance describes cleaning-method validation in similar terms: the objective is to provide documented evidence that an approved procedure produces clean equipment suitable for its intended purpose.
The important word is consistently. Cleaning a machine successfully once does not establish that the same procedure will work reliably after future production runs. Validation considers the defined cleaning method, the equipment and surfaces involved, the residues being removed, the sampling approach, the analytical method, and the acceptance criteria used to judge the result.
So what does “clean enough” actually mean?
It does not generally mean proving that absolutely no residue exists. Analytical methods have defined detection and quantification capabilities, and pharmaceutical cleaning decisions are based on justified acceptance criteria. Equipment is considered acceptably clean when relevant residues are controlled within established limits and the result is supported by appropriate inspection, örnekleme, ve test etme.
Visual cleanliness is still useful, but it cannot normally serve as the only acceptance criterion. A product-contact surface can appear clean while small amounts of residue remain. AB GMP Eki 15 therefore treats visual inspection as an important part of cleaning validation while stating that it is generally not acceptable to rely on visual cleanliness alone.
It is also useful to separate three related terms:
- Temizlik is the physical process of removing residues and contaminants from equipment.
- Cleaning verification checks whether a particular cleaning event meets defined requirements.
- Cleaning validation establishes documented evidence that the defined cleaning process performs consistently under the conditions for which it was designed.
This distinction explains why pharmaceutical cleaning validation goes beyond inspecting a machine after washing. The objective is to build evidence that the cleaning process is repeatable, measurable, and appropriate for the products and equipment involved.
Exactly where the acceptable limit should be set is a separate question. It depends on the type of residue, the next product, the equipment train, and the applicable risk assessment. These factors form the basis of cleaning validation acceptance criteria and are addressed later when we examine health-based limits and allowable carryover.
What Does GMP Require for Pharmaceutical Cleaning Validation?
GMP does not provide one cleaning recipe for every product or machine. It requires controlled, documented cleaning and evidence that equipment can be reused without unacceptable contamination or carryover risk.
FDA 21 CFR 211.67 requires written procedures for cleaning, denetleme, protection of clean equipment, and records. AB GMP Eki 15 addresses justified carryover limits, sampling locations, kabul kriterleri, and analytical methods. WHO guidance also supports a risk-based approach, especially for shared equipment.
| Kaynak | Main focus | Practical meaning |
| FDA 21 CFR Parçası 211 | Cleaning procedures, equipment design, denetleme, records | Cleaning must be defined, checked, and documented |
| AB GMP Eki 15 | Validation, limits, örnekleme, analitik yöntemler | Cleaning effectiveness needs supporting evidence |
| WHO guidance | Risk, Health-based exposure limit (HBEL), doğrulama, lifecycle control | The strategy should reflect actual product and carryover risk |
The important distinction is that regulators define the control objective; the manufacturer justifies the specific cleaning procedure, limits, sampling plan, and test methods for its own process.
How Do You Decide Whether Equipment Is Clean Enough?
The decision is easier to understand as a sequence:
Identify the residue → set an acceptable limit → sample the equipment → measure the residue → compare the result with the limit.
If the result meets the justified acceptance criteria and the cleaning procedure can repeatedly achieve that result, the equipment is clean enough for the validated use.
1. Define What Needs to Be Controlled
The previous product is usually the primary concern, but the assessment can also include cleaning-agent residues and, where relevant, microbiological contamination. Visual inspection is useful, but a visually clean surface can still contain low-level residue.
2. Set the Acceptance Criteria
For product residues in shared facilities, A health-based exposure limit (HBEL) can provide the scientific basis for deciding how much exposure to a previous product is acceptable. A permitted daily exposure (PDE) is one type of health-based value used in this assessment.
That health-based value is then translated into a practical carryover limit for the relevant product sequence and equipment train. This is commonly expressed as a Maximum Allowable Carryover (MACO) or another justified carryover limit.
The relationship is:
Toxicological data → HBEL/PDE → allowable carryover → equipment or surface limit → test result → Pass or Fail
A MACO calculation in cleaning validation therefore does not create one number that works for every machine or product. The result depends on the products involved and the assumptions used. This is also why a fixed historical rule such as 10 ppm should not automatically replace a scientifically justified risk assessment.
3. Compare the Evidence With the Limits
| Check | Main question |
| Görsel inceleme | Is visible residue absent under the defined inspection standard? |
| Product residue test | Is measured carryover below the justified limit? |
| Cleaning-agent residue | Is the cleaning agent below its established limit? |
| Microbiological assessment | Where applicable, are the defined criteria met? |
| Method capability | Can sampling and analysis reliably detect residue at the required level? |
A result of “not detected” does not mean zero residue. It means the residue was not detected above the capability of the sampling and analytical method. Clean enough is therefore a measured, justified condition—not a claim of perfect cleanliness.
How Pharmaceutical Cleaning Validation Works Step by Step
Pratik cleaning validation protocol turns those acceptance criteria into a repeatable study.
Adım 1: Define the Scope and Worst Case
Identify the product-contact equipment, the products that share it, and the combinations that create the most demanding cleaning conditions. Worst-case selection should consider more than one factor. Toxicity or potency affects the consequence of carryover, while poor solubility or difficult cleanability affects how hard the residue is to remove.
The product with the highest dose is therefore not automatically the worst cleaning case. The rationale should reflect both risk if residue remains and difficulty of removing it.
Adım 2: Define the Cleaning Procedure
The procedure should describe the variables that affect cleaning performance, such as cleaning-agent concentration, sıcaklık, contact time, rinsing, disassembly, kurutma, and relevant dirty or clean hold times. Manual cleaning also needs clear instructions because operator technique can introduce variation.
Adım 3: Choose Sampling Locations and Methods
Sampling should include meaningful locations, especially difficult-to-clean surfaces rather than only easy-to-reach areas.
Swab sampling gives a location-specific result from an accessible surface. Rinse sampling is useful for enclosed or hard-to-reach areas but gives less information about exactly where residue was located.
| Method | Main strength | Main limitation |
| Swab sampling | Direct, location-specific result | Limited to accessible surfaces |
| Rinse sampling | Covers enclosed or difficult areas | Less location-specific |
| Görsel inceleme | Fast and useful | Cannot quantify low-level chemical residue |
Adım 4: Select the Analytical Method
The method should fit the residue and the acceptance limit.
HPLC is useful when the study needs a specific measurement of a particular API or cleaning residue. TOC measures total organic carbon, so it can support a broader non-specific assessment when total organic residue is an appropriate indicator.
The correct choice depends on required specificity, sensitivity, detection capability, and the nature of the residue—not on which method sounds more advanced.
Adım 5: Run the Validation and Evaluate Results
Perform the approved cleaning procedure under the defined conditions, collect the planned samples, and compare the results with the predefined criteria. Failures should be investigated rather than repeatedly cleaned and retested until a passing result appears.
There is no universal rule that every cleaning validation study must always use exactly three successful runs. AB GMP Eki 15 calls for an appropriate number based on risk assessment and achievement of the acceptance criteria.
Adım 6: Maintain the Validated State
Onaylandıktan sonra, relevant changes to products, teçhizat, cleaning procedures, or operating conditions should be assessed through change control to determine whether additional verification or revalidation is justified.
How Pharmaceutical Equipment Design Affects Pharmaceutical Cleaning Validation
The cleaning procedure is what is validated, but equipment design influences how easily it can be performed and verified.
On an otomatik kapsül dolum makinası, the hopper, dosing components, and discharge path need practical cleaning access. A döner tablet pres makinesi needs accessible feeder and compression areas. bir pharmaceutical powder mixer, the vessel, discharge area, mühürler, and internal contact surfaces affect cleanability and sampling access.
FDA equipment requirements support the same principle: equipment should be designed and located to facilitate cleaning and maintenance, and product-contact surfaces should not adversely affect product quality.
Ruida Packaging'de çalışıyor, material-contact parts use 316L stainless steel, while other stainless-steel areas use 304 paslanmaz çelik. Accessible and removable product-contact structures can make routine cleaning more practical. Fakat, no stainless-steel grade or machine design automatically makes a cleaning process GMP-compliant. The manufacturer still needs to establish acceptance criteria, cleaning procedures, and validation evidence for the actual products and operating conditions.
Frequently Asked Questions About Pharmaceutical Cleaning Validation
What is the difference between cleaning validation and cleaning verification?
Cleaning validation establishes evidence that a cleaning process performs consistently. Cleaning verification checks whether a specific cleaning event or routine application meets defined requirements.
How often should cleaning validation be performed?
There is no single universal interval. Reassessment depends on process risk, değişiklikler, the validated state, company procedures, and applicable regulatory expectations.
Are three consecutive cleaning validation runs always required?
No. Three runs are used in some company programs, but EU GMP Annex 15 calls for an appropriate number based on risk assessment rather than a universal fixed number.
Is swab sampling better than rinse sampling?
Neither is universally better. Swabbing gives location-specific surface data; rinse sampling helps assess enclosed or difficult-to-access areas. The equipment and residue determine the appropriate strategy.
Which pharmaceutical equipment needs cleaning validation?
The main focus is product-contact equipment where ineffective cleaning could create unacceptable carryover or contamination risk. The exact scope depends on the products, işlem, equipment use, and risk assessment.
Bu yüzden, how clean is clean enough? Pharmaceutical cleaning validation answers that question through a clear chain of evidence: identify the relevant residue, establish a scientifically justified limit, sample representative surfaces, measure the residue with a suitable method, and show that the cleaning procedure can consistently meet the acceptance criteria.
Good equipment design makes cleaning and sampling easier, Ancak clean enough is ultimately demonstrated by the validated cleaning process and its data—not by appearance, malzeme seçimi, or machine design alone.
Referanslar
- BİZ. Federal Düzenlemelerin Elektronik Kodu. 21 CFR Parçası 211, Alt Bölüm D - Ekipman, including §211.63, §211.65, and §211.67.
- Avrupa Komisyonu. EudraLex Hacmi 4, Annex 15: Yeterlilik ve Doğrulama, Section 10—Cleaning Validation.
- Dünya Sağlık Örgütü. TRS 1033, Annex 2: Points to Consider When Including Health-Based Exposure Limits in Cleaning Validation.
- Avrupa İlaç Ajansı. Guideline on Setting Health-Based Exposure Limits for Use in Risk Identification in the Manufacture of Different Medicinal Products in Shared Facilities.
- BİZ. Gıda ve İlaç İdaresi. Validation of Cleaning Processes (7/93).
